If you’ve been told that your knee arthritis is simply “wear and tear,” you’ve probably also been told to live with the pain until it’s bad enough for a knee replacement.
But over the past decade, regenerative medicine has opened up another possibility: mesenchymal stem cell (MSC) therapy.
So, can stem cells actually regrow cartilage?
The honest answer is not yet—not conclusively. However, the latest clinical evidence suggests that stem cell therapy may offer meaningful benefits for many people with knee osteoarthritis, particularly by reducing pain, improving function, and creating a healthier environment inside the joint.
Let’s look at what the science actually tells us.
What are Mesenchymal Stem Cells (MSCs)?
Mesenchymal stem cells are specialised cells found naturally in tissues such as bone marrow, fat (adipose tissue), and umbilical cord tissue.
Unlike embryonic stem cells, MSCs do not replace damaged cartilage by simply becoming new cartilage cells. Instead, researchers now believe their greatest strength lies in their ability to:
- reduce inflammation
- regulate the immune response
- release growth factors
- encourage surrounding cartilage cells to repair themselves
- improve the joint environment
Many scientists now describe MSCs as “medicinal signalling cells” rather than simple replacement cells.
Does Stem Cell Therapy Really Regrow Cartilage?
This is where many advertisements overstate the evidence.
At present, there is no strong clinical evidence that a single MSC injection reliably regrows large amounts of cartilage in patients with established knee osteoarthritis.
MRI studies have generally shown little or inconsistent structural cartilage regeneration.
However, many patients experience:
- less pain
- improved mobility
- better knee function
- improved quality of life
These improvements can occur even without obvious cartilage regrowth on MRI scans.
What Did the Latest 2025 Research Find?
A major systematic review and meta-analysis published in Stem Cell Research & Therapy in 2025 analysed randomised controlled trials involving patients with knee osteoarthritis.
The researchers concluded that intra-articular MSC injections significantly improved:
- WOMAC pain scores
- physical function
- stiffness
- overall patient outcomes
Importantly, the treatment demonstrated a reassuring safety profile, with adverse events generally mild and temporary.
Another 2025 meta-analysis comparing MSC therapy with hyaluronic acid found that MSC injections produced greater improvements in pain and knee function while maintaining a similar safety profile.
So Why Isn’t Stem Cell Therapy Considered a Proven Cure?
Because medicine requires more than encouraging early results.
Researchers continue to highlight several important limitations:
- relatively small clinical trials
- different sources of stem cells
- different cell doses
- different processing methods
- different injection techniques
- relatively short follow-up periods
These differences make it difficult to compare studies directly and determine the optimal treatment protocol.
Is Some of the Improvement Simply Placebo?
Interestingly, one 2025 analysis asked exactly that question.
It suggested that while expectations and the treatment experience itself contribute to symptom improvement—as they do with many medical procedures—MSC therapy still appears to provide an additional biological benefit beyond placebo, although the size of that benefit may be more modest than some earlier reports suggested.
This is precisely why high-quality, blinded clinical trials remain so important.
Who May Benefit Most?
Current evidence suggests MSC therapy may be most helpful for people who:
- have mild to moderate knee osteoarthritis
- continue to experience pain despite physiotherapy or medication
- wish to delay joint replacement surgery
- remain physically active and want to maintain mobility
Patients with severe “bone-on-bone” arthritis can still experience symptom relief, but the likelihood of restoring joint function is generally lower, and knee replacement may remain the most effective long-term solution.
Is Stem Cell Therapy Safe?
Across published randomised trials, MSC injections have generally demonstrated a favourable safety profile.
Most reported side effects include:
- temporary pain
- swelling
- joint stiffness for a few days
Serious complications have been uncommon in properly conducted clinical studies.
As with any medical procedure, treatment should only be performed by appropriately trained clinicians using regulated, quality-controlled cell products.
The Bottom Line
The science surrounding stem cell therapy is progressing rapidly.
Today’s evidence does not support claims that MSC therapy can reliably regrow cartilage or permanently cure arthritis.
What it does support is something perhaps just as meaningful for many patients:
- reduced knee pain
- improved daily function
- better mobility
- improved quality of life
- the possibility of delaying joint replacement for selected patients
The field continues to evolve, and larger, longer-term studies are underway to determine which patients benefit most, what cell sources are optimal, and whether future regenerative techniques can achieve true cartilage restoration.
At Catalyst Clinic, we believe patients deserve clear, evidence-based information—not exaggerated promises. Stem cell therapy is an exciting area of regenerative medicine, but every treatment decision should be based on a careful assessment of your condition, your goals, and the best available clinical evidence.
References
- Cao M, et al. Efficacy and safety of mesenchymal stem cells in knee osteoarthritis: A systematic review and meta-analysis of randomized controlled trials. Stem Cell Research & Therapy. 2025.
- Jin WS, et al. Mesenchymal Stem Cells Injection Is More Effective Than Hyaluronic Acid Injection in the Treatment of Knee Osteoarthritis With Similar Safety. Arthroscopy. 2025.
- Kim EH, et al. Progressing future osteoarthritis treatment toward precision medicine. 2025.
- Yin F, et al. Contextual effects of mesenchymal stem cell injections for knee osteoarthritis. Frontiers in Medicine. 2025.
- Shahrezaee M, et al. Cartilage Repair in 2025: Hope, Hype, or Horizon? 2025.